Cronos Group (TSE:CRON) Trading Up 1.4% – Should You Buy?

Shares of Cronos Group Inc. (TSE:CRON) were up 1.4% during trading on Tuesday . The company traded as high as C$3.56 and last traded at C$3.55. Approximately 115,604 shares traded hands during mid-day trading, a decline of 32% from the average daily volume of 169,199 shares. The stock had previously closed at C$3.50.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on CRON shares. TD Securities set a C$4.50 target price on Cronos Group and gave the company a “buy” rating in a research note on Tuesday, February 24th. Canaccord Genuity Group set a C$4.25 price target on Cronos Group and gave the stock a “buy” rating in a research note on Tuesday, January 27th. Two investment analysts have rated the stock with a Buy rating, According to MarketBeat.com, the company currently has an average rating of “Buy” and a consensus price target of C$4.38.

Cronos Group Price Performance

The business has a fifty day moving average price of C$3.59 and a 200 day moving average price of C$3.60. The company has a debt-to-equity ratio of 0.25, a current ratio of 19.59 and a quick ratio of 24.01. The company has a market capitalization of C$1.35 billion, a price-to-earnings ratio of -177.50, a price-to-earnings-growth ratio of 0.12 and a beta of 1.18.

About Cronos Group

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S.